News Conference News TCT 2025 LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI L.A. McKeown October 27, 2025
News Conference News TCT 2024 Pooled All-Female Analysis Support Benefits of TAVI Over SAVR L.A. McKeown November 01, 2024
News Conference News TCT 2024 SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD L.A. McKeown October 29, 2024
News Conference News TCT 2023 PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions L.A. McKeown October 31, 2023
News Conference News TCT 2021 DCBs in Coronaries? Some Good News, but More Work Needed L.A. McKeown November 06, 2021
News Conference News TCT 2021 Disrupt CAD III Shows Sustained Benefit for Lithotripsy at 1 Year L.A. McKeown November 05, 2021
News Conference News TCT 2021 FAVOR III China Adds Strength to Value of QFR-Guided PCI L.A. McKeown November 04, 2021
News Conference News TCT 2021 OPTIMIZE: 2-Year DES Data Affirm Need for Meaningful MI Definitions L.A. McKeown October 25, 2021
News Conference News TCT 2021 NSTEMI Patients With CKD See Better Outcomes With Invasive Strategy L.A. McKeown October 22, 2021
News Conference News TCT 2020 EXAMINATION Surprise: Few Late Event Gaps Between DES and BMS in STEMI L.A. McKeown October 22, 2020
News Conference News TCT 2020 IN.PACT BTK Provides Renewed Hope for Attacking CLI With DCBs L.A. McKeown October 18, 2020
News Conference News TCT 2020 OPTIMIZE: Svelte Direct Stenting Device Fails to Match DES L.A. McKeown October 17, 2020
News Daily News TCT 2019 BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On L.A. McKeown October 02, 2019
News Conference News TCT 2019 LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD L.A. McKeown September 28, 2019
News Conference News TCT 2019 ‘Spooky’ Signal Still Haunts Paclitaxel DCBs in PAD, but Updated Analysis Reassures L.A. McKeown September 28, 2019
News Conference News TCT 2019 Onyx ONE: Shorter DAPT Plus ZES Noninferior to Polymer-Free Stent in High-Bleeding-Risk Patients L.A. McKeown September 26, 2019
News Conference News TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year L.A. McKeown November 28, 2011